Cargando…

Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy

Developing biomimetic nanoparticles without loss of the integrity of proteins remains a major challenge in cancer chemotherapy. Here, we develop a biocompatible tumor-cell-exocytosed exosome-biomimetic porous silicon nanoparticles (PSiNPs) as drug carrier for targeted cancer chemotherapy. Exosome-sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yong, Tuying, Zhang, Xiaoqiong, Bie, Nana, Zhang, Hongbo, Zhang, Xuting, Li, Fuying, Hakeem, Abdul, Hu, Jun, Gan, Lu, Santos, Hélder A., Yang, Xiangliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707218/ https://www.ncbi.nlm.nih.gov/pubmed/31444335 http://dx.doi.org/10.1038/s41467-019-11718-4

Ejemplares similares

Tumor-repopulating cell-derived microparticles elicit cascade amplification of chemotherapy-induced antitumor immunity to boost anti-PD-1 therapy
por: Bie, Nana, et al.
Publicado: (2023)

A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation
por: Xu, Qingbo, et al.
Publicado: (2018)

Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
por: Li, Xin, et al.
Publicado: (2022)

Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8(+) T cells to boost anti-PD-1 therapy
por: Zhang, Xiaoqiong, et al.
Publicado: (2023)

Biodegradable electrospun nanofibrous platform integrating antiplatelet therapy-chemotherapy for preventing postoperative tumor recurrence and metastasis
por: Li, Jianye, et al.
Publicado: (2022)

Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
por: Wei, Zhaohan, et al.
Publicado: (2021)

Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors
por: Xu, Qingbo, et al.
Publicado: (2021)

Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
por: Huang, Wenjing, et al.
Publicado: (2018)

Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release
por: Hakeem, Abdul, et al.
Publicado: (2018)

A Novel Magnetic Nanoparticle Drug Carrier for Enhanced Cancer Chemotherapy
por: Chao, Xu, et al.
Publicado: (2012)

Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies
por: Fu, Wei, et al.
Publicado: (2022)

Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p
por: Han, Shenqi, et al.
Publicado: (2023)

Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications
por: Zhang, Feng, et al.
Publicado: (2021)

Highly Efficient and Sustainable Spent Mushroom Waste Adsorbent Based on Surfactant Modification for the Removal of Toxic Dyes
por: Alhujaily, Ahmad, et al.
Publicado: (2018)

Exosomes as Drug Carriers in Anti-Cancer Therapy
por: Chen, Lan, et al.
Publicado: (2022)

Engineered Cell‐Derived Microparticles Bi(2)Se(3)/DOX@MPs for Imaging Guided Synergistic Photothermal/Low‐Dose Chemotherapy of Cancer
por: Wang, Dongdong, et al.
Publicado: (2019)

Exosome/Liposome-like Nanoparticles: New Carriers for CRISPR Genome Editing in Plants
por: Alghuthaymi, Mousa A., et al.
Publicado: (2021)

The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System
por: Li, Tianwei, et al.
Publicado: (2022)

Exosomes: potential diagnostic markers and drug carriers for adenomyosis
por: Cheng, Wen-Xiu, et al.
Publicado: (2023)

Research Advances of Engineered Exosomes as Drug Delivery Carrier
por: Huang, Lianghui, et al.
Publicado: (2023)

Silver Nanoparticles as Carriers of Anticancer Drugs for Efficient Target Treatment of Cancer Cells
por: Gomes, Helena I. O., et al.
Publicado: (2021)

Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
por: Zhang, Jiahui, et al.
Publicado: (2022)

Exosomes as Carriers of Alzheimer's Amyloid-ß
por: Yuyama, Kohei, et al.
Publicado: (2017)

Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
por: Selvamuthukumar, Subramanian, et al.
Publicado: (2012)

Doxorubicin‐loaded nanoparticle coated with endothelial cells‐derived exosomes for immunogenic chemotherapy of glioblastoma
por: Zhang, Chao, et al.
Publicado: (2020)

Combinational antitumor strategies of exosomes as drug carriers: Mini review
por: Xiao, Guixiu, et al.
Publicado: (2023)

Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma
por: Galardi, Angela, et al.
Publicado: (2023)

Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration
por: Lu, Ye, et al.
Publicado: (2023)

Identification of the SNARE complex that mediates the fusion of multivesicular bodies with the plasma membrane in exosome secretion
por: Liu, Chuqi, et al.
Publicado: (2023)

A novel and efficient fungal delignification strategy based on versatile peroxidase for lignocellulose bioconversion
por: Kong, Wen, et al.
Publicado: (2017)

Chitosan Nanoparticles as Oral Drug Carriers
por: Guadarrama-Escobar, Omar Rodrigo, et al.
Publicado: (2023)

Dual role of nanoparticles as drug carrier and drug
por: Patra, Hirak Kumar, et al.
Publicado: (2011)

Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy
por: Zou, Liang, et al.
Publicado: (2021)

Aptamer-modified DNA tetrahedra-gated metal–organic framework nanoparticle carriers for enhanced chemotherapy or photodynamic therapy
por: Zhang, Pu, et al.
Publicado: (2021)

Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer
por: Zhao, Xiaojing, et al.
Publicado: (2014)

Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA
por: Nair K, Lekha, et al.
Publicado: (2011)

Responsive Dual-Targeting Exosome as a Drug Carrier for Combination Cancer Immunotherapy
por: Fan, Yuanyuan, et al.
Publicado: (2021)

Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung()
por: Popowski, Kristen D., et al.
Publicado: (2022)

Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2022)

Endogenous Lipid Carriers—Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes
por: Richards, Terjahna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qhh6eag3efrv4o1uf45up20jah